IMVT - Latest News

Immunovant, Inc. (IMVT), operates in Healthcare / Biotechnology, trades on NASDAQ.

Market capitalization stands near $8.63B. Beta to the broader market is 0.81.

The article list below shows the most recent IMVT headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent IMVT Headlines

Immunovant, Inc. (IMVT) Q1 2027 Earnings Call Transcript

seekingalpha.com - Aug 6, 2026

Immunovant, Inc.

Immunovant Q1 Earnings Call Highlights

marketbeat.com - Aug 6, 2026

Roivant said its first quarter was relatively quiet operationally but positioned the company for a more active second half of 2026, with a potential l

Immunovant's Q1 Loss Wider Than Expected, Pipeline in Progress

zacks.com - Aug 6, 2026

IMVT posts a wider quarterly loss as R&D spending rises, but its cash runway supports IMVT-1402 through a planned Graves' disease commercial launch.

Immunovant Provides Corporate Updates and Reports Financial Results for the Quarter Ended June 30, 2026

globenewswire.com - Aug 6, 2026

All IMVT-1402 clinical development timelines remain on track, including ongoing studies in Graves' disease (GD), myasthenia gravis (MG), chronic infla

Immunovant: Risk-Reward Set-Up Compelling, Initiating With A Speculative Buy

seekingalpha.com - Jul 27, 2026

I initiate coverage of Immunovant with a BUY rating and a $50 price target, driven by optimism around IMVT-1402's differentiated profile. IMVT-1402 d

How News Affects IMVT Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track IMVT's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked IMVT news questions

What is the latest IMVT news headline?

The most recent IMVT headline (Aug 6, 2026) is "Immunovant, Inc. (IMVT) Q1 2027 Earnings Call Transcript". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.

How fresh is the IMVT news on this page?

News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.

What IMVT news moves options pricing?

Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.

How can I track unusual IMVT options activity related to news?

Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.